ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
企業コードCLPT
会社名Clearpoint Neuro Inc
上場日Jul 03, 2019
最高経営責任者「CEO」Burnett (Joseph Michael)
従業員数115
証券種類Ordinary Share
決算期末Jul 03
本社所在地120 S. Sierra Avenue
都市SOLANA BEACH
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号92075
電話番号19499006833
ウェブサイトhttps://www.clearpointneuro.com/
企業コードCLPT
上場日Jul 03, 2019
最高経営責任者「CEO」Burnett (Joseph Michael)
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし